Hyaluronic Viscosupplementation Market Projected to Grow to USD 4.3 Billion by 2035, Driven by Rising Demand for Non-Surgical Osteoarthritis Treatments

The global hyaluronic viscosupplementation market is on a steady growth trajectory, with an estimated value of USD 2.7 billion in 2025, projected to reach USD 4.3 billion by 2035. This represents a compound annual growth rate (CAGR) of 4.9% during the forecast period. The increasing prevalence of osteoarthritis, combined with a growing preference for minimally invasive treatments, is fueling this market's expansion. Additionally, advancements in hyaluronic acid formulations and delivery techniques are enhancing treatment outcomes, driving adoption across key regions.

Unlock detailed analytics - Request your personalized report now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-17713

Market Drivers and Key Trends

Hyaluronic viscosupplementation, a non-surgical treatment primarily used for knee osteoarthritis, is gaining popularity due to its ability to reduce pain and improve joint mobility. The rise in joint-related disorders, particularly knee osteoarthritis, is contributing to the demand for effective therapies that require fewer visits to healthcare facilities. This treatment method has become an attractive alternative to invasive surgical procedures, as it offers substantial relief with minimal downtime.

The market is witnessing a surge in innovation, with leading players focusing on the development of advanced hyaluronic acid formulations that improve safety, efficacy, and patient compliance. Cross-linked hyaluronic acid with higher molecular weights is one of the key innovations driving growth, as it provides longer-lasting effects compared to traditional formulations. Additionally, single-dose injections, which offer convenience and reduced clinical visits, are expected to dominate the market, with the single injection knee hyaluronic acid injections segment expected to account for 32.2% of market revenue by 2025.

Segmental Insights

Single Injection Knee Hyaluronic Acid Injections:
This segment is poised to lead the market due to the increasing demand for single-dose therapies. These injections deliver high concentrations of hyaluronic acid, which improves joint lubrication and reduces pain. The convenience and extended relief offered by single injections have made them a preferred choice among patients and healthcare providers. The market share of this segment is expected to grow significantly over the next decade.

Knee Body Part Segment:
Knee osteoarthritis remains the most common application for hyaluronic viscosupplementation, contributing to approximately 35.6% of the market revenue in 2025. The knee joint is particularly vulnerable to wear and degeneration due to its weight-bearing function, making it a prime target for viscosupplementation. Advances in injection techniques and improved patient outcomes are driving the popularity of knee injections.

High Molecular Weight Hyaluronic Acid:
The high molecular weight hyaluronic acid segment is expected to dominate the market, accounting for 38.2% of the revenue in 2025. This formulation has superior viscoelastic properties, offering better joint lubrication and shock absorption, which are critical for reducing pain and improving mobility in osteoarthritis patients.

Regional Insights

North America:
North America, particularly the United States, is set to maintain its position as the dominant region for hyaluronic viscosupplementation. With a large aging population and high prevalence of knee osteoarthritis, the U.S. market is projected to capture 50% of the global market share in 2025. The increasing coverage of viscosupplementation under Medicare and commercial insurance is further driving adoption.

Asia-Pacific:
The Asia-Pacific region, including countries like Japan and China, is expected to experience substantial growth in the hyaluronic viscosupplementation market. In Japan, the high prevalence of knee osteoarthritis, coupled with the reluctance of patients to undergo surgery, has made viscosupplementation a preferred treatment option. China, with its significant burden of knee osteoarthritis, is also poised for market expansion, with an estimated contribution of USD 157.8 million to the East Asia market in 2025.

Competitive Landscape

The hyaluronic viscosupplementation market is highly competitive, with several key players leading the charge in product development and market penetration. Major companies in this market include Anika Therapeutics Inc., Zimmer Biomet, Sanofi S.A., LG Chem, Chugai Pharmaceutical Co., Ltd., and Ferring B.V., among others. These companies are focusing on strategic collaborations, acquisitions, and R&D investments to expand their product offerings and improve market share.

For example, Bioventus, Inc. recently acquired CartiHeal Ltd. to enhance its portfolio in joint cartilage repair, while Avanos Medical acquired OrthogenRx to expand its viscosupplementation offerings. These strategic acquisitions are expected to accelerate the development of innovative treatments and expand the market reach of key players.

Challenges and Restraints

Despite the promising growth prospects, the hyaluronic viscosupplementation market faces certain challenges. There is ongoing debate regarding the long-term efficacy of viscosupplementation treatments, with some studies questioning the clinical benefits. Additionally, some patients may experience adverse reactions to hyaluronic acid injections, leading to hesitancy in adoption. Furthermore, national and international guidelines in certain regions discourage the use of hyaluronic acid derivatives, which may limit market growth.

Outlook

The hyaluronic viscosupplementation market is expected to continue its upward trajectory, driven by the growing demand for non-surgical treatments for osteoarthritis and advancements in treatment efficacy. As awareness of the benefits of viscosupplementation grows, along with improvements in injection techniques and product formulations, the market is well-positioned for sustained growth over the next decade.

Get Full Access of this Report:
https://www.futuremarketinsights.com/reports/hyaluronic-viscosupplementation-market

Explore Related Research Reports on Healthcare Domain

Artificial Tears Market:
https://www.futuremarketinsights.com/reports/artificial-tears-market

Cervical Dysplasia Treatment Market:
https://www.futuremarketinsights.com/reports/cervical-dysplasia-treatment-market

Rheumatoid Arthritis Therapeutics Market:
https://www.futuremarketinsights.com/reports/rheumatoid-arthritis-therapeutics-market

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.